Fingerprint
Dive into the research topics of 'Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis
Takahiro Nishio, Yukinori Koyama, Xiao Liu, Sara B. Rosenthal, Gen Yamamoto, Hiroaki Fuji, Jacopo Baglieri, Na Li, Laura N. Brenner, Keiko Iwaisako, Kojiro Taura, James S. Hagood, Nicholas F. LaRusso, Tapan K. Bera, Ira Pastan, David A. Brenner, Tatiana Kisseleva
Research output: Contribution to journal › Article › peer-review